Strand Life Sciences expands onco-genomic portfolio in India with the globally benchmarked 152-gene StrandAdvantage test
https://strandls.com/wp-content/themes/osmosis/images/empty/thumbnail.jpg 150 150 Strand Administrator Strand Administrator https://secure.gravatar.com/avatar/37b6376b831060698759d4503de53810?s=96&d=mm&r=gDecember 20, 2016 | Bangalore, India It is vital for oncologists to get clinically actionable and timely results to decide on treatment options for…
read more